Contract Manufacturing

What are the Challenges of Contract Pharma Manufacturing in India

The Contract Manufacturing Organizations industry, based on geography, places India at the top of the list. The combination of low cost of labor, high-skilled personnel, and infrastructure makes India a favorable destination for outsourcing. However, India is faced with a few challenges, such as a lack of regulatory structure, quality inconsistencies, and supply chain issues, which are among the most critical ones. India is recognized as one of the leading countries providing outsourced services, hence, all these issues need to be resolved. To be efficient and retain the competitive edge of these services in the global marketplace, these issues need to be addressed. About this, the following blog will analyze the primary issues and provide suggestions for optimizing improvement in India’s contract manufacturing of pharmaceuticals.

Major Challenges in Contract Pharma Manufacturing in India

India is known to have great potential in contract pharma manufacturing, however, there is a lot of unexploited potential that needs to be tackled. A few of the major problems that are faced by the contract pharma manufacturers are as follows:

  • The greatest challenge remains meeting regulatory compliance. Under the Drug Controller General of India (DCGI) and external bodies such as the FDA and WHO-GMP, India’s pharmaceutical sector is mandated to follow stringent drug regulations. Not complying may lead to problems such as suspension of operations or product recalls.
  • Besides, maintaining optimal standards of quality and uniformity over different batches of medicines is another challenge. Straying from a set benchmark of the quality standards of raw materials used, manufacturing processes, and storage of the drugs can be dangerous and harmful. Quality control standards and extensive testing procedures must be followed by the manufacturers.
  • Supply chain disruptions are also a very serious issue. Reliance on overseas imported raw materials, fluctuations in exchange rates, and delays in shipping all impact production calendars. Additionally, the recent global supply chain shortages have greatly emphasized the need for strategically located and fortified procurement plans.
  • Additionally, gaps in infrastructure and tech enable difficulties in manufacturing. Furthermore, not every manufacturer has the modern instruments required for efficient manufacturing. There is a need to invest in contract manufacturing of pharma products to counter new upgrades and modern technologies.

What Ways Can Challenges Faced in Contract Pharma Manufacturing in India be Settled?

  • Secondary Requirements for Compliance Documents

Pharmaceuticals must follow set regulations for every country they intend to sell their products, such as their product’s national and international approval. Competent marketing also incorporates obtaining all relevant documents, such as the WHO-GMP, FDA, and ISO. Alongside these certifications, proper quality control management needs to be exercised throughout the whole production line. Consistency of the product is attained through third party inspection, in-plant quality inspection, and auditing. Consistency and precision can be gleaned from investing in automated quality control systems.

  • Strategic Management of Supplies to boost overall Productivity

Medicinal contract manufacturing in India is heavily reliant on having a strong supply base. To mitigate risk, the scope level of dependable suppliers must be maintained alongside a suitable amount of backbone raw materials. Working with dependable logistics firms ensures that goods reach their destination without any distractions. Predicting shipping delays and actions required to be taken can be attained through the systems set in place for tracking shipment delivery.

  • Investment in Automation Technologies and Skilled Manpower

In the long run, firms need to implement automation, AI control, and data analysis to be successful in contract manufacturing for pharma products. Such technologies increase efficiency, minimize human error, and enhance productivity. Moreover, the employees need to be periodically trained. Also, training on new production procedures, regulatory changes, quality control, and efficient operation is essential. Thus, an educated workforce ensures greater accuracy and creativity in drug formulations.

Conclusion

The Contract Pharma Manufacturing in India is already a thriving business with immense opportunities to further boom in the pharmaceutical industry. Compliance, quality, supply chain, and technology are critical for a business to be successful. Indorama Pharma is already setting industry benchmarks with its comprehensive quality control checks, investments in new-age technology, and compliance with international norms. A partnership with Indorama Pharma helps pharmaceutical businesses expand their reach while guaranteeing high-quality products and market reliability.

Scroll to Top

Enquire Now